{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:05:27Z","timestamp":1791140727714,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.clon.2007.02.007","type":"journal-article","created":{"date-parts":[[2007,3,10]],"date-time":"2007-03-10T06:55:53Z","timestamp":1173509753000},"page":"289-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"title":["Is the \u03b1\/\u03b2 Value for Prostate Tumours Low Enough to be Safely Used in Clinical Trials?"],"prefix":"10.1016","volume":"19","author":[{"given":"A.","family":"Da\u015fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2007.02.007_bib1","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0360-3016(98)00438-6","article-title":"Fractionation and protraction for radiotherapy of prostate carcinoma","volume":"43","author":"Brenner","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0360-3016(00)00442-9","article-title":"Is the prostrate \u03b1\/\u03b2 ratio of 1.5 from Brenner\u00a0& Hall a modeling artifact?","volume":"47","author":"King","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0360-3016(00)00443-0","article-title":"In response to Drs. King and Mayo: low \u03b1\/\u03b2 values for prostate appear to be independent of modeling details","volume":"47","author":"Brenner","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib4","first-page":"747","article-title":"What is the \u03b1\/\u03b2 ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy","volume":"44","author":"Duchesne","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0360-3016(00)00591-5","article-title":"Toward optimal external-beam fractionation for prostate cancer","volume":"48","author":"Brenner","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0360-3016(01)01607-8","article-title":"Is \u03b1\/\u03b2 for prostate tumors really low?","volume":"50","author":"Fowler","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0360-3016(01)01651-0","article-title":"A simple analytic derivation suggests that prostate cancer \u03b1\/\u03b2 ratio is low","volume":"51","author":"King","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0360-3016(01)01650-9","article-title":"Is the \u03b1\/\u03b2 ratio for prostate cancer low?","volume":"51","author":"D'Souza","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0360-3016(01)02665-7","article-title":"The prospects for new treatments for prostate cancer","volume":"52","author":"Fowler","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","article-title":"Direct evidence that prostate tumors show high sensitivity to fractionation (low \u03b1\/\u03b2 ratio), similar to late-responding normal tissue","volume":"52","author":"Brenner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib11","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S0360-3016(02)02859-6","article-title":"In regard to Brenner et\u00a0al., IJROBP 2002;52:6\u201313","volume":"53","author":"Lee","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib12","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0360-3016(02)02860-2","article-title":"In response to Dr. Lee","volume":"53","author":"Brenner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0360-3016(02)02922-X","article-title":"Yes, the \u03b1\/\u03b2 ratio for prostate cancer is low or \u2018methinks the lady doth protest too much\u2026about a low \u03b1\/\u03b2 that is\u2019","volume":"54","author":"King","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0360-3016(02)02923-1","article-title":"In response to Drs. King and Fowler","volume":"54","author":"Thames","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0360-3016(03)00132-9","article-title":"What hypofractionated protocols should be tested for prostate cancer?","volume":"56","author":"Fowler","year":"2003","journal-title":"Int\u00a0J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0360-3016(03)01456-1","article-title":"Hypofractionation for prostate cancer radiotherapy\u00a0\u2014 what are the issues?","volume":"57","author":"Brenner","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib17","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1118\/1.2179008","article-title":"Point\/counterpoint. The best radiotherapy for the treatment of prostate cancer involves hypofractionation","volume":"33","author":"Fowler","year":"2006","journal-title":"Med Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1088\/0031-9155\/48\/3\/308","article-title":"Should single or distributed parameters be used to explain the steepness of tumour control probability curves?","volume":"48","author":"Da\u015fu","year":"2003","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clon.2007.02.007_bib19","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1118\/1.1612946","article-title":"Comparison of \u03b1\/\u03b2 estimates from homogeneous (individual) and heterogeneous (population) tumor control models for early stage prostate cancer","volume":"30","author":"Carlone","year":"2003","journal-title":"Med Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib20","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1118\/1.1711415","article-title":"TCP isoeffect analysis using a heterogeneous distribution of radiosensitivity","volume":"31","author":"Carlone","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/02841860410032777","article-title":"Effect of heterogeneity in radiosensitivity on LQ based isoeffect formalism for low \u03b1\/\u03b2 cancers","volume":"43","author":"Moiseenko","year":"2004","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clon.2007.02.007_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1088\/0031-9155\/48\/4\/307","article-title":"The influence of brachytherapy dose heterogeneity on estimates of \u03b1\/\u03b2 for prostate cancer","volume":"48","author":"Lindsay","year":"2003","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clon.2007.02.007_bib23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0360-3016(02)03828-2","article-title":"How low is the \u03b1\/\u03b2 ratio for prostate cancer?","volume":"55","author":"Wang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0360-3016(03)00747-8","article-title":"The low \u03b1\/\u03b2 ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us?","volume":"57","author":"Wang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib25","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0360-3016(03)01455-X","article-title":"How low is the \u03b1\/\u03b2 ratio for prostate cancer?","volume":"57","author":"Kal","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0360-3016(91)90731-I","article-title":"The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience","volume":"21","author":"Lai","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00130404-200411000-00004","article-title":"Impact of elapsed treatment time on outcome of external-beam radiation therapy for localized carcinoma of the prostate","volume":"10","author":"Perez","year":"2004","journal-title":"Cancer J"},{"key":"10.1016\/j.clon.2007.02.007_bib28","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1097-0142(19940715)74:2<670::AID-CNCR2820740220>3.0.CO;2-8","article-title":"Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer","volume":"74","author":"Pollack","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2007.02.007_bib29","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.ijrobp.2004.08.034","article-title":"Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation","volume":"61","author":"Buyyounouski","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0360-3016(03)00364-X","article-title":"How low is the \u03b1\/\u03b2 ratio for prostate cancer? In regard to Wang et\u00a0al., IJROBP 2003;55:194\u2013203","volume":"57","author":"Fowler","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0360-3016(03)00363-8","article-title":"Low \u03b1\/\u03b2 ratio for prostate cancer: in response to Dr. Fowler et al","volume":"57","author":"Wang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib32","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1088\/0031-9155\/49\/16\/012","article-title":"Prostate implant evaluation using tumour control probability \u2014 the effect of input parameters","volume":"49","author":"Haworth","year":"2004","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clon.2007.02.007_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0360-3016(00)00562-9","article-title":"A comment on proliferation rates in human prostate cancer","volume":"48","author":"Haustermans","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib34","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1088\/0031-9155\/50\/6\/L01","article-title":"Comments on \u2018Comparison of in vitro and in vivo \u03b1\/\u03b2 ratios for prostate cancer\u2019","volume":"50","author":"Da\u015fu","year":"2005","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clon.2007.02.007_bib35","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1088\/0031-9155\/49\/19\/003","article-title":"Comparison of in vitro and in vivo \u03b1\/\u03b2 ratios for prostate cancer","volume":"49","author":"Carlson","year":"2004","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.clon.2007.02.007_bib36","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0360-3016(01)02814-0","article-title":"Is the \u03b1\/\u03b2 for prostate tumors really low? In regard to Fowler et\u00a0al., IJROBP 2001;50:1021\u20131031","volume":"52","author":"Dale","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib37","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0360-3016(01)02815-2","article-title":"In response to Drs. Dale and Jones","volume":"52","author":"Chappell","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0360-3016(03)00534-0","article-title":"Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the \u03b1\/\u03b2 ratio","volume":"57","author":"Nahum","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijrobp.2004.08.043","article-title":"Modeling prostate cancer: in regards to Nahum et\u00a0al. (Int J Radiat Oncol Biol Phys 2003;57:391\u2013401)","volume":"61","author":"Wang","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijrobp.2004.08.045","article-title":"In response to Dr. Wang et al","volume":"61","author":"Nahum","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.canrad.2005.09.013","article-title":"Hypofractionnement en radioth\u00e9rapie: le retour?","volume":"9","author":"Cosset","year":"2005","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.clon.2007.02.007_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0090-4295(90)80207-4","article-title":"Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years\u2019 experience (1962\u20131984)","volume":"36","author":"Lloyd-Davies","year":"1990","journal-title":"Urology"},{"key":"10.1016\/j.clon.2007.02.007_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0936-6555(05)80831-3","article-title":"Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique","volume":"3","author":"Collins","year":"1991","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2007.02.007_bib44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0360-3016(99)00454-X","article-title":"Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland","volume":"46","author":"Mohan","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib45","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0360-3016(02)02836-5","article-title":"Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy\/fraction) for localized prostate cancer","volume":"53","author":"Kupelian","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib46","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.ijrobp.2005.05.054","article-title":"Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: long term outcomes","volume":"63","author":"Kupelian","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib47","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0360-3016(03)00752-1","article-title":"Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis","volume":"57","author":"Livsey","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib48","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0360-3016(00)01565-0","article-title":"Hypofractionation for prostate cancer","volume":"49","author":"Logue","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib49","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijrobp.2003.10.033","article-title":"External beam radiotherapy for clinically node-negative, localized hormone-refractory prostate cancer: impact of pretreatment PSA value on radiotherapeutic outcomes","volume":"59","author":"Akimoto","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib50","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ijrobp.2004.07.695","article-title":"Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding","volume":"60","author":"Akimoto","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib51","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib52","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ijrobp.2006.06.005","article-title":"Hypofractionated vs conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial","volume":"66","author":"Yeoh","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib53","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0360-3016(02)04146-9","article-title":"Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a phase III randomized trial","volume":"55","author":"Yeoh","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib54","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0167-8140(03)80402-4","article-title":"A randomized trial comparing two fractionation schedules for patients with localised prostate cancer","volume":"69","author":"Lukka","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2007.02.007_bib55","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1200\/JCO.2005.06.153","article-title":"Randomized trial comparing two fractionation schedules for patients with localized prostate cancer","volume":"23","author":"Lukka","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2007.02.007_bib56","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ijrobp.2004.06.204","article-title":"New data on the value of \u03b1\/\u03b2 \u2014 evidence mounts that it is low","volume":"60","author":"Chappell","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2005.06.009","article-title":"The alpha\/beta ratio for prostate cancer: what is it, really?","volume":"76","author":"Bentzen","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2007.02.007_bib58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.radonc.2004.12.019","article-title":"Is the alpha\u2013beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy","volume":"75","author":"Valdagni","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2007.02.007_bib59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0167-8140(97)00121-7","article-title":"Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma","volume":"44","author":"Borghede","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2007.02.007_bib60","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0360-3016(98)00097-2","article-title":"High dose-rate afterloading 192iridium prostate brachytherapy: feasibility report","volume":"41","author":"Mate","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib61","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0302-2838(02)00016-7","article-title":"High dose rate brachytherapy of localized prostate cancer","volume":"41","author":"Deger","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.clon.2007.02.007_bib62","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/01.ju.0000052720.62999.a9","article-title":"Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors","volume":"169","author":"Martinez","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2007.02.007_bib63","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0360-3016(03)00081-6","article-title":"High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity","volume":"56","author":"Yoshioka","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib64","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2006.06.011","article-title":"High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer","volume":"80","author":"Yoshioka","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2007.02.007_bib65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-8140(02)00408-5","article-title":"Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer","volume":"66","author":"Pellizzon","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2007.02.007_bib66","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ijrobp.2003.08.003","article-title":"Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer","volume":"58","author":"Galalae","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib67","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijrobp.2003.11.035","article-title":"Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer","volume":"59","author":"Hiratsuka","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib68","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.urology.2004.04.015","article-title":"High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer","volume":"64","author":"Jo","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.clon.2007.02.007_bib69","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2004.08.014","article-title":"High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results","volume":"61","author":"Demanes","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib70","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2004.04.014","article-title":"Fractionation and late rectal toxicity","volume":"60","author":"Brenner","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib71","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0360-3016(97)00560-9","article-title":"The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE)","volume":"40","author":"Wang","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0167-8140(01)00429-7","article-title":"Consequential late effects in normal tissues","volume":"61","author":"D\u00f6rr","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2007.02.007_bib73","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0360-3016(01)02591-3","article-title":"Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer","volume":"52","author":"Jereczek-Fossa","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib74","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijrobp.2005.01.015","volume":"62","author":"Fiorino","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib75","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijrobp.2005.01.014","article-title":"In response to Dr. Fiorino et al","volume":"62","author":"Brenner","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib76","series-title":"Fractionation in radiotherapy","author":"Thames","year":"1987"},{"key":"10.1016\/j.clon.2007.02.007_bib77","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijrobp.2004.11.041","volume":"63","author":"Akimoto","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0360-3016(03)00086-5","article-title":"Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer","volume":"56","author":"Amer","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib79","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0360-3016(03)00638-2","article-title":"The impact of geometric uncertainty on hypofractionated external beam radiation therapy of prostate cancer","volume":"57","author":"Craig","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib80","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0360-3016(03)00746-6","article-title":"Intrafractional stability of the prostate using a stereotactic radiotherapy technique","volume":"57","author":"Madsen","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib81","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.clon.2005.07.006","article-title":"Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy","volume":"17","author":"Khoo","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2007.02.007_bib82","first-page":"1035","article-title":"Nei\u0161plitusio prie\u0161ines liaukos ve\u017eio hipofrakcionuoto spindulinio gydymo saugumo tyrimas [A preliminary safety study of hypofractionated radiotherapy for local prostate cancer]","volume":"41","author":"Norkus","year":"2005","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.clon.2007.02.007_bib83","series-title":"AAPM Symposium Proceedings No. 14: Physical, Chemical and Biological Targeting in Radiation Oncology","first-page":"131","article-title":"Acute toxicity following hypofractionated conformal radiotherapy of localized prostate cancer. A nonrandomized contemporary comparison with standard fractionation","author":"Leborgne","year":"2005"},{"key":"10.1016\/j.clon.2007.02.007_bib84","series-title":"AAPM Symposium Proceedings No. 14: Physical, Chemical and Biological Targeting in Radiation Oncology","first-page":"182","article-title":"Phase I\/II trial of dose-perfraction escalation for prostate cancer","author":"Ritter","year":"2005"},{"key":"10.1016\/j.clon.2007.02.007_bib85","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0167-8140(03)00231-7","article-title":"Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules","volume":"69","author":"Fowler","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2007.02.007_bib86","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1118\/1.599003","article-title":"An analysis of the relationship between radiosensitivity and volume effects in tumor control probability modeling","volume":"27","author":"Buffa","year":"2000","journal-title":"Med Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib87","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0360-3016(01)01731-X","article-title":"Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data","volume":"51","author":"Levegr\u00fcn","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2007.02.007_bib88","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0167-8140(05)81141-7","article-title":"Dose escalation radiotherapy of prostate cancer","volume":"76","author":"Widmark","year":"2005","journal-title":"Radiother Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655507005183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655507005183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:32:13Z","timestamp":1760542333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655507005183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0936655507005183"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2007.02.007","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the \u03b1\/\u03b2 Value for Prostate Tumours Low Enough to be Safely Used in Clinical Trials?","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2007.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}